BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nair AT, Ramachandran V, Joghee NM, Antony S, Ramalingam G. Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review. J Neurogastroenterol Motil 2018;24:30-42. [PMID: 29291606 DOI: 10.5056/jnm17105] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 19.8] [Reference Citation Analysis]
Number Citing Articles
1 Kwon KY, Park S, Kim RO, Lee EJ, Lee M. Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease. Sci Rep 2022;12:11461. [PMID: 35794147 DOI: 10.1038/s41598-022-15630-8] [Reference Citation Analysis]
2 Sun H, Zhao F, Liu Y, Ma T, Jin H, Quan K, Leng B, Zhao J, Yuan X, Li Z, Li F, Kwok LY, Zhang S, Sun Z, Zhang J, Zhang H. Probiotics synergized with conventional regimen in managing Parkinson's disease. NPJ Parkinsons Dis 2022;8:62. [PMID: 35610236 DOI: 10.1038/s41531-022-00327-6] [Reference Citation Analysis]
3 Brandau L, Weis S, Weyland M, Berger FK, Schnell S, Schäfer K, Egert M. RNA-based stable isotope probing provides no indication for rapid α-synuclein assimilation by murine gut bacteria. Access Microbiology 2022;4. [DOI: 10.1099/acmi.0.000345] [Reference Citation Analysis]
4 Sonali S, Ray B, Ahmed Tousif H, Rathipriya AG, Sunanda T, Mahalakshmi AM, Rungratanawanich W, Essa MM, Qoronfleh MW, Chidambaram SB, Song BJ. Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review. Cells 2022;11:1362. [PMID: 35456041 DOI: 10.3390/cells11081362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Chidambaram SB, Rathipriya AG, Mahalakshmi AM, Sharma S, Hediyal TA, Ray B, Sunanda T, Rungratanawanich W, Kashyap RS, Qoronfleh MW, Essa MM, Song BJ, Monaghan TM. The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke. Cells 2022;11:1239. [PMID: 35406804 DOI: 10.3390/cells11071239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Luan M, Jin J, Wang Y, Li X, Xiea A. Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population. Neurosci Lett 2022;:136547. [PMID: 35218888 DOI: 10.1016/j.neulet.2022.136547] [Reference Citation Analysis]
7 Kramer P. Mitochondria-Microbiota Interaction in Neurodegeneration. Front Aging Neurosci 2021;13:776936. [PMID: 35002678 DOI: 10.3389/fnagi.2021.776936] [Reference Citation Analysis]
8 Wu G, Jiang Z, Pu Y, Chen S, Wang T, Wang Y, Xu X, Wang S, Jin M, Yao Y, Liu Y, Ke S, Liu S. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients. BMC Neurol 2022;22:13. [PMID: 34996385 DOI: 10.1186/s12883-021-02544-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
9 Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clin Microbiol Rev 2022;:e0033820. [PMID: 34985325 DOI: 10.1128/CMR.00338-20] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
10 Anis E, Xie A, Brundin L, Brundin P. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease. Trends Endocrinol Metab 2021:S1043-2760(21)00268-X. [PMID: 34949514 DOI: 10.1016/j.tem.2021.11.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Russo E. The gut microbiota as a biomarker in epilepsy. Neurobiol Dis 2021;163:105598. [PMID: 34942335 DOI: 10.1016/j.nbd.2021.105598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Barrio C, Arias-Sánchez S, Martín-Monzón I. The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review. Psychoneuroendocrinology 2021;137:105640. [PMID: 34942539 DOI: 10.1016/j.psyneuen.2021.105640] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
13 Chidambaram SB, Essa MM, Rathipriya AG, Bishir M, Ray B, Mahalakshmi AM, Tousif AH, Sakharkar MK, Kashyap RS, Friedland RP, Monaghan TM. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Pharmacol Ther 2021;:107988. [PMID: 34536490 DOI: 10.1016/j.pharmthera.2021.107988] [Reference Citation Analysis]
14 Yan Y, Ren S, Duan Y, Lu C, Niu Y, Wang Z, Inglis B, Ji W, Zheng Y, Si W. Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease. NPJ Biofilms Microbiomes 2021;7:69. [PMID: 34475403 DOI: 10.1038/s41522-021-00242-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
15 Jones JD, Dominguez B, Bunch J, Uribe C, Valenzuela Y, Jacobs JP. A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson's disease. Clin Park Relat Disord 2021;5:100104. [PMID: 34430845 DOI: 10.1016/j.prdoa.2021.100104] [Reference Citation Analysis]
16 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Mol Med Rep 2021;24:734. [PMID: 34414447 DOI: 10.3892/mmr.2021.12374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Broxmeyer HE, Yoder KK, Wu YC, Hutchins GD, Cooper SH, Farag SS. The Brain: Is it a Next Frontier to Better Understand the Regulation and Control of Hematopoiesis for Future Modulation and Treatment? Stem Cell Rev Rep 2021;17:1083-90. [PMID: 34255283 DOI: 10.1007/s12015-021-10203-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Trichka J, Zou WQ. Modulation of Neuroinflammation by the Gut Microbiota in Prion and Prion-Like Diseases. Pathogens 2021;10:887. [PMID: 34358037 DOI: 10.3390/pathogens10070887] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Yemula N, Dietrich C, Dostal V, Hornberger M. Parkinson's Disease and the Gut: Symptoms, Nutrition, and Microbiota. J Parkinsons Dis 2021. [PMID: 34250955 DOI: 10.3233/JPD-212707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Vamanu E, Rai SN. The Link between Obesity, Microbiota Dysbiosis, and Neurodegenerative Pathogenesis. Diseases 2021;9:45. [PMID: 34201465 DOI: 10.3390/diseases9030045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
21 Vacca L, Proietti S, Bravi D, Radicati FG, Stocchi F. Effectiveness of an herbaceous derivatives, PHGG, plus sodium hyaluronate in the treatment of chronic constipation in patients with Parkinson's disease: a pilot study. Neurol Sci 2021. [PMID: 34086122 DOI: 10.1007/s10072-021-05342-8] [Reference Citation Analysis]
22 Sardelli L, Perottoni S, Tunesi M, Boeri L, Fusco F, Petrini P, Albani D, Giordano C. Technological tools and strategies for culturing human gut microbiota in engineered in vitro models. Biotechnol Bioeng 2021;118:2886-905. [PMID: 33990954 DOI: 10.1002/bit.27816] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
23 Cheslow L, Snook AE, Waldman SA. Emerging targets for the diagnosis of Parkinson's disease: examination of systemic biomarkers. Biomark Med 2021;15:597-608. [PMID: 33988462 DOI: 10.2217/bmm-2020-0654] [Reference Citation Analysis]
24 Huang Y, Liao J, Liu X, Zhong Y, Cai X, Long L. Review: The Role of Intestinal Dysbiosis in Parkinson's Disease. Front Cell Infect Microbiol 2021;11:615075. [PMID: 33968794 DOI: 10.3389/fcimb.2021.615075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
25 Sun C, Armstrong MJ. Treatment of Parkinson's Disease with Cognitive Impairment: Current Approaches and Future Directions. Behav Sci (Basel) 2021;11:54. [PMID: 33920698 DOI: 10.3390/bs11040054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
26 Chen ZJ, Liang CY, Yang LQ, Ren SM, Xia YM, Cui L, Li XF, Gao BL. Association of Parkinson's Disease With Microbes and Microbiological Therapy. Front Cell Infect Microbiol 2021;11:619354. [PMID: 33763383 DOI: 10.3389/fcimb.2021.619354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Dogra N, Mani RJ, Katare DP. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease. Cell Mol Neurobiol 2021. [PMID: 33649989 DOI: 10.1007/s10571-021-01066-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
28 Lee SYH, Yates NJ, Tye SJ. Inflammatory Mechanisms in Parkinson's Disease: From Pathogenesis to Targeted Therapies. Neuroscientist 2021;:1073858421992265. [PMID: 33586516 DOI: 10.1177/1073858421992265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Shen T, Yue Y, He T, Huang C, Qu B, Lv W, Lai HY. The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis. Front Aging Neurosci 2021;13:636545. [PMID: 33643026 DOI: 10.3389/fnagi.2021.636545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
30 Utembe W, Kamng'ona AW. Gut microbiota-mediated pesticide toxicity in humans: Methodological issues and challenges in the risk assessment of pesticides. Chemosphere 2021;271:129817. [PMID: 33736210 DOI: 10.1016/j.chemosphere.2021.129817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Rajput C, Sarkar A, Sachan N, Rawat N, Singh MP. Is Gut Dysbiosis an Epicenter of Parkinson's Disease? Neurochem Res 2021;46:425-38. [PMID: 33400024 DOI: 10.1007/s11064-020-03187-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Vuuren MJV, Nell TA, Carr JA, Kell DB, Pretorius E. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson's Disease. Biomolecules 2020;11:E30. [PMID: 33383805 DOI: 10.3390/biom11010030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
33 Polito R, Di Meo I, Barbieri M, Daniele A, Paolisso G, Rizzo MR. Adiponectin Role in Neurodegenerative Diseases: Focus on Nutrition Review. Int J Mol Sci 2020;21:E9255. [PMID: 33291597 DOI: 10.3390/ijms21239255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Liu J, Xu F, Nie Z, Shao L. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease. Front Cell Infect Microbiol 2020;10:570658. [PMID: 33194809 DOI: 10.3389/fcimb.2020.570658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
35 Gamage R, Wagnon I, Rossetti I, Childs R, Niedermayer G, Chesworth R, Gyengesi E. Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation. Front Cell Neurosci 2020;14:577912. [PMID: 33192323 DOI: 10.3389/fncel.2020.577912] [Cited by in Crossref: 10] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
36 Kim J, Choi JH, Ko G, Jo H, Oh T, Ahn B, Unno T. Anti-Inflammatory Properties and Gut Microbiota Modulation of Porphyra tenera Extracts in Dextran Sodium Sulfate-Induced Colitis in Mice. Antioxidants (Basel) 2020;9:E988. [PMID: 33066339 DOI: 10.3390/antiox9100988] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
37 Suganya K, Koo BS. Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. Int J Mol Sci 2020;21:E7551. [PMID: 33066156 DOI: 10.3390/ijms21207551] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 18.5] [Reference Citation Analysis]
38 Tang W, Zhu H, Feng Y, Guo R, Wan D. The Impact of Gut Microbiota Disorders on the Blood-Brain Barrier. Infect Drug Resist 2020;13:3351-63. [PMID: 33061482 DOI: 10.2147/IDR.S254403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
39 Gong SQ, Ye TT, Wang MX, Hong ZP, Liu L, Chen H, Qian J. Profiling the mid-adult cecal microbiota associated with host healthy by using herbal formula Kang ShuaiLao Pian treated mid-adult mice. Chin J Nat Med 2020;18:90-102. [PMID: 32172952 DOI: 10.1016/S1875-5364(20)30010-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
40 Song S, Liu J, Zhang F, Hong JS. Norepinephrine depleting toxin DSP-4 and LPS alter gut microbiota and induce neurotoxicity in α-synuclein mutant mice. Sci Rep 2020;10:15054. [PMID: 32929122 DOI: 10.1038/s41598-020-72202-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
41 Cordaillat-Simmons M, Rouanet A, Pot B. Live biotherapeutic products: the importance of a defined regulatory framework. Exp Mol Med 2020;52:1397-406. [PMID: 32908212 DOI: 10.1038/s12276-020-0437-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
42 Liao JF, Cheng YF, You ST, Kuo WC, Huang CW, Chiou JJ, Hsu CC, Hsieh-Li HM, Wang S, Tsai YC. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease. Brain Behav Immun 2020;90:26-46. [PMID: 32739365 DOI: 10.1016/j.bbi.2020.07.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
43 Ceppa FA, Izzo L, Sardelli L, Raimondi I, Tunesi M, Albani D, Giordano C. Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling. Front Cell Infect Microbiol 2020;10:297. [PMID: 32733812 DOI: 10.3389/fcimb.2020.00297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
44 Song K, Li Y, Zhang H, An N, Wei Y, Wang L, Tian C, Yuan M, Sun Y, Xing Y, Gao Y. Oxidative Stress-Mediated Blood-Brain Barrier (BBB) Disruption in Neurological Diseases. Oxidative Medicine and Cellular Longevity 2020;2020:1-27. [DOI: 10.1155/2020/4356386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
45 Mohamed NV, Larroquette F, Beitel LK, Fon EA, Durcan TM. One Step Into the Future: New iPSC Tools to Advance Research in Parkinson's Disease and Neurological Disorders. J Parkinsons Dis 2019;9:265-81. [PMID: 30741685 DOI: 10.3233/JPD-181515] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
46 Isaiah S, Loots DT, Solomons R, van der Kuip M, Tutu Van Furth AM, Mason S. Overview of Brain-to-Gut Axis Exposed to Chronic CNS Bacterial Infection(s) and a Predictive Urinary Metabolic Profile of a Brain Infected by Mycobacterium tuberculosis. Front Neurosci 2020;14:296. [PMID: 32372900 DOI: 10.3389/fnins.2020.00296] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
47 Franco R, Rivas-Santisteban R, Reyes-Resina I, Navarro G, Martínez-Pinilla E. Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson's Disease. Front Aging Neurosci 2020;12:12. [PMID: 32226375 DOI: 10.3389/fnagi.2020.00012] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Xu L, Surathu A, Raplee I, Chockalingam A, Stewart S, Walker L, Sacks L, Patel V, Li Z, Rouse R. The effect of antibiotics on the gut microbiome: a metagenomics analysis of microbial shift and gut antibiotic resistance in antibiotic treated mice. BMC Genomics. 2020;21:263. [PMID: 32228448 DOI: 10.1186/s12864-020-6665-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
49 Mozaffari S, Nikfar S, Daniali M, Abdollahi M. The pharmacological management of constipation in patients with Parkinson's disease: a much-needed relief. Expert Opin Pharmacother 2020;21:701-7. [PMID: 32037901 DOI: 10.1080/14656566.2020.1726319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Illiano P, Brambilla R, Parolini C. The mutual interplay of gut microbiota, diet and human disease. FEBS J 2019;287:833-55. [DOI: 10.1111/febs.15217] [Cited by in Crossref: 45] [Cited by in F6Publishing: 85] [Article Influence: 22.5] [Reference Citation Analysis]
51 Jones JD, Rahmani E, Garcia E, Jacobs JP. Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease. Parkinsonism Relat Disord 2020;72:7-12. [PMID: 32058266 DOI: 10.1016/j.parkreldis.2020.01.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
52 Paprotny Ł, Celejewska A, Frajberg M, Wianowska D. Development and validation of GC-MS/MS method useful in diagnosing intestinal dysbiosis. J Chromatogr B Analyt Technol Biomed Life Sci 2019;1130-1131:121822. [PMID: 31669633 DOI: 10.1016/j.jchromb.2019.121822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
53 Bullich C, Keshavarzian A, Garssen J, Kraneveld A, Perez-Pardo P. Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis. Mov Disord Clin Pract 2019;6:639-51. [PMID: 31745471 DOI: 10.1002/mdc3.12840] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 6.7] [Reference Citation Analysis]
54 Li T, Le W. Biomarkers for Parkinson's Disease: How Good Are They? Neurosci Bull 2020;36:183-94. [PMID: 31646434 DOI: 10.1007/s12264-019-00433-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
55 McGee DJ, Lu XH, Disbrow EA. Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease. J Parkinsons Dis 2018;8:367-74. [PMID: 29966206 DOI: 10.3233/JPD-181327] [Cited by in Crossref: 29] [Cited by in F6Publishing: 39] [Article Influence: 9.7] [Reference Citation Analysis]
56 Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP. Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation. J Neurogastroenterol Motil 2019;25:363-76. [PMID: 31327219 DOI: 10.5056/jnm19044] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 21.0] [Reference Citation Analysis]
57 Uyar GÖ, Yildiran H. A nutritional approach to microbiota in Parkinson's disease. Biosci Microbiota Food Health 2019;38:115-27. [PMID: 31763115 DOI: 10.12938/bmfh.19-002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
58 Magistrelli L, Amoruso A, Mogna L, Graziano T, Cantello R, Pane M, Comi C. Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence. Front Immunol 2019;10:969. [PMID: 31134068 DOI: 10.3389/fimmu.2019.00969] [Cited by in Crossref: 27] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
59 Lubomski M, Tan AH, Lim SY, Holmes AJ, Davis RL, Sue CM. Parkinson's disease and the gastrointestinal microbiome. J Neurol 2020;267:2507-23. [PMID: 31041582 DOI: 10.1007/s00415-019-09320-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 65] [Article Influence: 14.3] [Reference Citation Analysis]
60 Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. Journal of Neuroimmunology 2019;328:98-104. [DOI: 10.1016/j.jneuroim.2019.01.004] [Cited by in Crossref: 90] [Cited by in F6Publishing: 110] [Article Influence: 30.0] [Reference Citation Analysis]
61 Ning YZ, Wu FZ, Xue S, Yin DQ, Zhu H, Liu J, Jia HX. Enhanced functional connectivity of the default mode network (DMN) in patients with spleen deficiency syndrome: A resting-state fMRI study. Medicine (Baltimore) 2019;98:e14372. [PMID: 30702629 DOI: 10.1097/MD.0000000000014372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 Kowalski K, Mulak A. Brain-Gut-Microbiota Axis in Alzheimer's Disease. J Neurogastroenterol Motil 2019;25:48-60. [PMID: 30646475 DOI: 10.5056/jnm18087] [Cited by in Crossref: 306] [Cited by in F6Publishing: 277] [Article Influence: 102.0] [Reference Citation Analysis]
63 Shu L, Liang D, Pan H, Xu Q, Yan X, Tang B, Sun Q. Gastrointestinal Dysfunctions Are Associated with IL-10 Variants in Parkinson's Disease. Parkinsons Dis 2018;2018:5908359. [PMID: 30631418 DOI: 10.1155/2018/5908359] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
64 Barichella M, Severgnini M, Cilia R, Cassani E, Bolliri C, Caronni S, Ferri V, Cancello R, Ceccarani C, Faierman S, Pinelli G, De Bellis G, Zecca L, Cereda E, Consolandi C, Pezzoli G. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism. Mov Disord 2019;34:396-405. [PMID: 30576008 DOI: 10.1002/mds.27581] [Cited by in Crossref: 89] [Cited by in F6Publishing: 115] [Article Influence: 22.3] [Reference Citation Analysis]
65 Mohamadkhani A. Gut Microbiota and Fecal Metabolome Perturbation in Children with Autism Spectrum Disorder. Middle East J Dig Dis 2018;10:205-12. [PMID: 31049167 DOI: 10.15171/mejdd.2018.112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
66 Caputi V, Giron MC. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease. Int J Mol Sci. 2018;19. [PMID: 29882798 DOI: 10.3390/ijms19061689] [Cited by in Crossref: 107] [Cited by in F6Publishing: 124] [Article Influence: 26.8] [Reference Citation Analysis]
67 Lombardi VC, De Meirleir KL, Subramanian K, Nourani SM, Dagda RK, Delaney SL, Palotás A. Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease. J Nutr Biochem 2018;61:1-16. [PMID: 29886183 DOI: 10.1016/j.jnutbio.2018.04.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
68 Zhang J, Culp ML, Craver JG, Darley-Usmar V. Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease. J Neurochem 2018;144:691-709. [PMID: 29341130 DOI: 10.1111/jnc.14308] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]